Book Value per Share: cytekbio.com (CTKB)

Graphic logo of Cytek Biosciences Inc (CTKB)

The price action visualization for Cytek Biosciences, Inc. (CTKB) demonstrates the market quotes of a company that generates revenue by supplying advanced cytometers to medical centers and pharmaceutical laboratories for cellular diagnostics. Business resilience is ensured by the variability of optics suppliers, which maintains the margin at 2.49. Growth is driven by demand in oncology and immunology, while profitability increases due to regular sales of high-cost consumables.

Cytek Biosciences Inc (CTKB) - Accounting Value per Share from 07/04/2022 to 10/26/2026

Summary analytical data breakdowns for cytekbio.com (CTKB)

- price and consensus price forecast:
Price Chart Cytek Bio|CTKB - Analyst Consensus Forecast
- market capitalization data:
Market Capitalization Cytek Biosciences, Inc.|CTKB - Total Company Value
- book capitalization data:
Net Assets per Single Share Cytek Biosciences|CTKB - Company Net Assets|Market Capitalization to Book Value Ratio cytekbio.com|CTKB - Company Assets
- debt and liquidity data:
Total Debt to Capital Cytek Biosciences, Inc.|CTKB - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Cytek Biosciences|CTKB - Company Aggregate Debts|Debt to Book Capitalization Ratio Cytek Biosciences, Inc.
Fundamental company valuation:Cytek Biosciences, Inc.
Manufactured product of cytekbio.com

Cytek Biosciences, Inc. (CTKB) focuses on supplying high-tech spectral cytometry systems to research centers. An analysis of the book value per share determines the actual portion of net assets attributable to a single security. This calculation captures the business's asset backing, excluding market volatility. Growth in this metric confirms capital stability even amidst delivery delays of laser components. The positive trend of this indicator reduces investment risks due to the high margins of the ancillary services segment.

Competitors of Cytek Biosciences, Inc. (CTKB)

Agilent Tech - Net Assets per Single Share|DGX - Book Value per Share|Illumina, Inc. (ILMN) - Book Value per Share|EXAS (exactsciences.com) - Net Assets per Single Share|Net Assets per Single Share RVTY|Accounting Value per Share Bio-Rad Laboratories, Inc.|Anbio Tech - Book Value per Share|Net Asset Value per Share Nordion (SHC)|QDEL - Book Value per Share|Equity per Share opko.com OPK|CareDx, Inc - Book Value per Share|MRVI: Book Value per Share|Net Assets per Single Share Fulgent Corp|Standard BioTools Corp (LAB) - Equity per Share|OSUR (OraSure Technologies) - Book Value per Share|Book Value per Share XGN|Net Assets per Single Share MDxHealth (MDXH)|Net Assets per Single Share Lucid Diagnostics, Inc. LUCD|PRE: Accounting Value per Share|Insight Molecular Diagnostics, Inc. - Net Asset Value per Share|Net Assets per Single Share TRIB (Trinity Biotech Corp)|PRPH - Net Assets per Share|Ainos - Book Value per Share|CODX (Co-Diagnostics Inc) - Net Assets per Share|HSCS: Net Assets per Single Share|Net Assets per Share Biomerica Inc|Book Value per Share CDIO (Cardio Diagnostics)|Accounting Value per Share viraxbiolabs.com VRAX|BJDX: Accounting Value per Share|AWH - Net Asset Value per Share|Accounting Value per Share Accelerate Diagnostics, Inc AXDX|CNTG - Book Price of a Share|Book Value per Share ENZ|FRES (Fresh2 Group) - Net Asset Value per Share|GENE (Genetic Technologies Ltd) - Net Assets per Single Share|Book Value per Share 23andMe Holding Co (ME)|Psychemedics Corp (PMD) - Accounting Value per Share